Will Indivior turn, or will it continue to rise beyond September high of 277p?

• The chart shows the Indivior price action since mid-September.
• Shares in a 2-week uptrend from 176p November lows; now at 220p.
• Shares -58% from 2018 highs; +25.2% from 2018 lows; -46% year-to-date.
• Will the pattern continue, the shares rising beyond September high of 277p?
• 1 Nov: Q3 pre-tax profit increased on lower costs and the generic drugs company said it’s on track to hit FY targets.
• 2 Nov: Sales of opioid addiction treatment Suboxone were ahead of forecasts, says Jefferies.
• In November, the shares have risen close to 17%. Will this momentum continue?

Click to enlarge

Trading Indivior – An Example

Let’s say the trend appeals to you, you think it’s likely to continue. You decide to buy exposure to £10,000 worth of Indivior using a CFD, at the current price of 220p. To do this, you need £2,000.

Let’s assume Indivior trend continues to September high of 277p (+25.9%). Your profit would be £2590, from your initial investment of £2,000.

Conversely, let’s assume you open the above position, and place a stop-loss at 9% from the current price. Indivior falls 9% and hits your stop-loss. Your loss would be £900.

This is provided for information purposes only. It should not be taken as a recommendation.